Biohaven (BHVN) Profit After Tax (2021 - 2026)
Biohaven (BHVN) reported Profit After Tax of -$130.5 million for Q1 2026, up 41.12% on a YoY basis from -$92.5 million in Q1 2025, and up 10.29% sequentially from -$145.5 million in Q4 2025.
Biohaven (BHVN) Profit After Tax (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Profit After Tax data on file, last reported at -$130.5 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 41.12% year-over-year to -$130.5 million; the trailing twelve-month figure through Mar 2026 stood at -$647.6 million (up 27.1% YoY), and the FY2025 full-year result was -$738.8 million, up 12.71% from the prior year.
- Profit After Tax advanced to -$130.5 million in Q1 2026, from -$145.5 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$68.9 million in Q3 2022 to a low of -$319.8 million in Q2 2024.
- A 5-year average of -$158.5 million and a median of -$160.1 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax plunged 287.59% in 2022 and soared 55.56% in 2023, its largest moves.
- Tracing BHVN's Profit After Tax over 5 years: stood at -$201.1 million in 2022, then rose by 28.08% to -$144.6 million in 2023, then declined by 29.19% to -$186.8 million in 2024, then gained by 22.12% to -$145.5 million in 2025, then climbed by 10.29% to -$130.5 million in 2026.
- Business Quant data shows BHVN's Profit After Tax at -$130.5 million in Q1 2026, -$145.5 million in Q4 2025, and -$173.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Biohaven | 2.13 Bn | 1.78 Bn | - | -130.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.53 Mn |
| Dec 31, 2025 | -145.51 Mn |
| Sep 30, 2025 | -173.40 Mn |
| Jun 30, 2025 | -198.15 Mn |
| Mar 31, 2025 | -221.68 Mn |
| Dec 31, 2024 | -186.84 Mn |
| Sep 30, 2024 | -160.09 Mn |
| Jun 30, 2024 | -319.77 Mn |
| Mar 31, 2024 | -179.50 Mn |
| Dec 31, 2023 | -144.63 Mn |
| Sep 30, 2023 | -102.57 Mn |
| Jun 30, 2023 | -90.35 Mn |
| Mar 31, 2023 | -70.49 Mn |
| Dec 31, 2022 | -201.11 Mn |
| Sep 30, 2022 | -68.85 Mn |
| Jun 30, 2022 | -203.29 Mn |
| Mar 31, 2022 | -97.03 Mn |
| Dec 31, 2021 | -51.89 Mn |
| Sep 30, 2021 | -54.37 Mn |